deltatrials
Completed NA INTERVENTIONAL 1-arm NCT03562325

ACT for ME/CFS - an Open Case Trial

Acceptance & Commitment Therapy for ME/CFS (Chronic Fatigue Syndrome) - an Open Case Trial

Sponsor: Region Stockholm

Updated 5 times since 2018 Last updated: Jun 8, 2018 Started: Nov 10, 2012 Primary completion: Oct 31, 2017 Completion: Oct 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03562325, this NA trial focuses on Chronic Fatigue Syndrome and remains completed. Sponsored by Region Stockholm, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jul 2018 – ~Jan 2021 · 30 months · monthly snapshotCompleted~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotCompleted~Oct 2021 – ~Jul 2024 · 33 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Oct 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jan 2021 — Oct 2021 [monthly]

    Completed NA

  5. Jul 2018 — Jan 2021 [monthly]

    Completed NA

    First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Region Stockholm
  • Rikard Wicksell
  • Skandia Insurance Company, Ltd.
Data source: Karolinska Institutet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations